Latigo Biotherapeutics Inc.

NASDAQ:LTGO

Medical - Pharmaceuticals

Healthcare
$13.31 +5.43%

+$0.76 today

Market cap
$800.64M
Beta
0.00
52W Low $13.50High $25.93

Volume 0.21M

Average 0.38M

LTGO Total Current Assets

All assets expected to be converted to cash or used up within one year.

No reported Total Current Assets figures are available to summarize.

Total Current Assets history

Currency unavailable · from the balance sheet

No Total Current Assets data reported for this period type.

Total Current Assets vs competitors

How LTGO compares with its peers on the latest reported figures

LTGO Competitors
Total Current Assets for LTGO and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
COLLCollegium Pharmaceutical, Inc.Mar 2026$745.67M USD+41.3%+18.1%45.1%
PCRXPacira BioSciences, Inc.Mar 2026$514.96M USD-32.2%+3.2%42.6%
SCLXScilex Holding CompanyMar 2026$41.97M USD+46.2%+9.0%14.3%
LTGOLatigo Biotherapeutics Inc.—— ———
Peer median (excluding LTGO) —+41.3%+9.0%42.6%

Competitors are the stored peer set for LTGO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Latigo Biotherapeutics Inc.

NASDAQ:LTGO

Intrinsic Alpha fair value

Locked

Current Price

$13.31

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.